WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

The decline of real-life slimming clubs is down to a variety of factors, says Kate. ‘Diets come in fads — at the moment, ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

Among them, WW International (WW), formerly known as WeightWatchers, hit a rough patch earlier this year, resulting in WW ...

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced.

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage a comeback.

WeightWatchers said its forthcoming menopause programme — which will deliver “tailored nutritional and behavioural strategies” — is a “strategic move to address a broader gap in healthcare”.

The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.

Under the guise of “body positivity,” a brazen bridezilla sat all of her plus-size guests — including chunky close relatives — at table labeled “Weight Watchers.” ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and provide more health benefits.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs ...